News and publishing service for psychedelic related companies
Contact us:
512.354.7000
twitter
facebook
linkedin
News and publishing service for psychedelic related companies
Home
About
Clients
NewsRoom
Solutions
Events
Contact
PNW Headlines
NRx Pharmaceuticals Inc. (NRXP) Files Abbreviated New Drug Application for Preservative-Free IV Ketamine NRX-100
Republican Lawmakers Embrace Psychedelic Therapies in Shift Toward Veteran Mental Health Reform
Study Shows Psychedelic Use Could Lower Chances of Suffering Frequent Headaches
More People are Microdosing Psychedelics to Ease the Challenges of Parenting
DOD to Invest $9.8m into Psychedelic Studies Targeting Active-Duty Soldiers
PsychedelicNewsBreaks
PsychedelicNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Positioning at the Forefront of Next-Gen Treatment
NRx Pharmaceuticals Inc. (NRXP)
July 16, 2025
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire 49% Stake in Leading Florida Psychiatry Clinic
NRx Pharmaceuticals, Inc. (NRXP)
June 26, 2025
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Taps IBN to Lead Corporate Communications Amid Drug Advancements and Subsidiary Launch
NRx Pharmaceuticals Inc. (NRXP)
June 24, 2025
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s Priority Voucher for NRX-100 Ketamine Formulation
NRx Pharmaceuticals Inc. (NRXP)
June 23, 2025
PsychedelicNewsBreaks – Psyence Biomedical Ltd. (NASDAQ: PBM) to Present at Psychedelic Science 2025
Psyence Biomedical Ltd. (PBS)
June 18, 2025
View More PsychedelicNewsBreaks
PsychedelicNewsWire Articles
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic
NRx Pharmaceuticals, Inc. (NRXP)
July 8, 2025
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100
NRx Pharmaceuticals, Inc. (NRXP)
June 27, 2025
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Files Abbreviated New Drug Application for Preservative-Free IV Ketamine NRX-100 Amid Ongoing Shortage
NRx Pharmaceuticals, Inc. (NRXP)
June 12, 2025
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Signs Agreement to Acquire Kadima to Launch $100M Psychiatry Clinic Network
NRx Pharmaceuticals, Inc. (NRXP)
June 5, 2025
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Announces $10.3 Million Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval
NRx Pharmaceuticals, Inc. (NRXP)
May 28, 2025
View All PsychedelicNewsWire Articles
Public Press Releases
Filter Releases
Filters
Sector
Aerospace and Defense
Banking and Finance
Banking
Biotechnology
Internet
Media
Metal and Mineral
Medical Marijuana
Chemicals
Computer
Consumer Goods
Pharmaceutical
Oil & Energy
Real Estate
Software
Energy
Entertainment
Food and Beverage
Healthcare
Telecommunications
Transportation
Utilities
Remove All Filters
Symbol
Release
Time
Source
{{ release.qmtopics.qmsymbol[0].symbol }}
{{ release.headline }}
{{ release.datetime | amDateFormat:'hh:mm A'}}
{{ release.source }}
Load More
PsychedelicNewsWire Currently Accepts
Bitcoin
Bitcoin Cash
Dogecoin
Ethereum
Litecoin
USD Coin
Contact us:
512.354.7000